U.S. Securities & Exchange Commission
SEC Seal
Home | Search Home | Latest Filings | Previous Page
U.S. Securities and Exchange Commission


Atlas Venture Associates IX, LLC (0001671207)
State location: MA | State of Inc.: DE | Fiscal Year End: 1012
Business Address
56 WAREHAM STREET, FLOOR 3
BOSTON MA 02118
617-588-2694
Mailing Address
56 WAREHAM STREET, FLOOR 3
BOSTON MA 02118
Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.)

Issuer Filings Transaction Date Type of Owner
Surface Oncology, Inc. 0001718108 2020-12-17 10 percent owner
Unum Therapeutics, Inc.
Current Name:Cogent Biosciences, Inc.
0001622229 2018-03-28 10 percent owner
Spero Therapeutics, Inc. 0001701108 2017-11-01 10 percent owner
Intellia Therapeutics, Inc. 0001652130 2017-07-07 10 percent owner


Items 1 - 0

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition Transaction Date Deemed Execution Date Issuer Form Transaction Type Direct or Indirect Ownership Number of Securities Transacted Number of Securities Owned Line Number Issuer CIK Security Name

http://www.sec.gov/cgi-bin/own-disp


Modified: 04/22/2016